MDR1 gene polymorphisms and clinical relevance

Yi chuan xue bao = Acta genetica Sinica
Yan-Hong LiLing Yang

Abstract

In vivo and in vitro studies have demonstrated that P-glycoprotein (P-gp) plays a very significant role in the ADME processes (absorption, distribution, metabolism, excretion) and drug-drug interaction (DDI) of drugs in humans. P-gp is the product of multidrug resistance gene (MDR1/ABCB1). Pharmacogenomics and pharmacogenetics studies have revealed that genetic polymorphisms of MDR1 are associated with alteration in P-gp expression and function in different ethnicities and subjects. By now, 50 single nucleotide polymorphisms (SNPs) and 3 insertion/deletion polymorphisms have been found in the MDR1 gene. Some of them, such as C3435T, have been identified to be a risk factor for numerous diseases. It is believed that further understanding of the physiology and biochemistry of P-gp with respect to its genetic variations may be important for individualized pharmacotherapy. Therefore, based on the latest public information and our studies, this review focuses on the following four aspects: 1) the impact of P-gp on pharmacokinetics; 2) MDR1 genetic polymorphisms and their impacts on pharmacogenetics; 3) relationship between altered P-gp expression and function and the MDR1(C3435T) SNP, and 4) relevance of MDR1 polymorphisms to certai...Continue Reading

References

Nov 11, 1976·Biochimica Et Biophysica Acta·R L Juliano, V Ling
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F ThiebautM C Willingham
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C Cordon-CardoJ R Bertino
Jun 1, 1997·Seminars in Cancer Biology·H W van Veen, W N Konings
May 20, 1999·Annual Review of Pharmacology and Toxicology·S V AmbudkarM M Gottesman
Jul 20, 1999·The Journal of Clinical Investigation·B GreinerH K Kroemer
Feb 15, 2001·European Journal of Pharmacology·D MaimoneL M Grimaldi
Aug 15, 2001·Lancet·E SchaeffelerM Schwab
May 8, 2002·British Journal of Clinical Pharmacology·Siegfried DrescherMartin F Fromm
Jun 18, 2002·Molecular Pharmacology·Chava Kimchi-SarfatyMichael M Gottesman
Jun 29, 2002·Journal of the American Society of Nephrology : JASN·Michael SiegsmundHiltrud Brauch
Oct 31, 2002·Advanced Drug Delivery Reviews·Martin F Fromm
Nov 7, 2002·Biological & Pharmaceutical Bulletin·Toshiyuki SakaedaKatsuhiko Okumura
Jan 22, 2003·Advanced Drug Delivery Reviews·Jiunn H Lin
Jan 28, 2003·Therapeutic Drug Monitoring·Maria Luisa BernalEsteban Mayayo
Jul 2, 2003·Pharmacogenomics·Toshiyuki SakaedaKatsuhiko Okumura
Oct 25, 2003·Oncogene·Suresh V AmbudkarMichael M Gottesman
Feb 3, 2004·Current Medicinal Chemistry. Anti-cancer Agents·Guillermo A Altenberg
Feb 21, 2004·Human Molecular Genetics·Kun TangCaroline G L Lee
May 26, 2004·Best Practice & Research. Clinical Gastroenterology·Silvia MascherettiStefan Schreiber
Jun 26, 2004·Clinical Pharmacokinetics·Ichiro IeiriKenji Otsubo
Jul 2, 2004·Therapeutic Drug Monitoring·Michel EichelbaumMatthias Schwab
Sep 24, 2004·Current Topics in Medicinal Chemistry·Toshiyuki SakaedaKatsuhiko Okumura
Oct 27, 2004·Journal of Veterinary Pharmacology and Therapeutics·K L Mealey
Nov 24, 2004·Drug Metabolism Reviews·Ulrich Hoffmann, Heyo K Kroemer
Feb 19, 2005·International Journal of Hematology·Martin StanullaMatthias Schwab

❮ Previous
Next ❯

Citations

Apr 30, 2009·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Alma HamidovicJill Kolesar
Sep 26, 2012·Drug Metabolism and Pharmacokinetics·Eun Sil OhJae-Yong Chung
Jul 3, 2010·The American Journal of Tropical Medicine and Hygiene·Catherine BourguinatTimothy G Geary
Sep 23, 2014·Pathology, Research and Practice·M ZebrowskaE Balcerczak
Nov 28, 2014·European Journal of Drug Metabolism and Pharmacokinetics·Yuqing XiongMingyi Liu
Aug 1, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A Ayrton, P Morgan
Jan 24, 2012·Placenta·M IqbalS G Matthews
Jan 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Farzad MaroofiMohammad Abdi
Aug 20, 2016·Journal of the Neurological Sciences·Shiek S S J AhmedV Ramakrishnan
Jul 28, 2016·Expert Opinion on Drug Metabolism & Toxicology·Elena ArrigoniAntonello Di Paolo
Nov 15, 2017·Basic & Clinical Pharmacology & Toxicology·Miriam Saiz-RodríguezFrancisco Abad-Santos
May 4, 2018·Basic & Clinical Pharmacology & Toxicology·Miriam Saiz-RodríguezFrancisco Abad-Santos
May 31, 2011·Pharmacogenomics·Bruno Stieger, Peter J Meier
Jul 10, 2010·Leukemia & Lymphoma·Stephen DrainH Denis Alexander
May 14, 2016·International Journal of Oncology·Sabna Rajeev KrishnanMary Bebawy
Jan 28, 2020·British Journal of Pharmacology·Robert Eckenstaler, Ralf A Benndorf
Nov 17, 2020·Frontiers in Bioengineering and Biotechnology·Mariafrancesca CascioneRosaria Rinaldi
Dec 4, 2021·Drug Metabolism and Personalized Therapy·Idania Rodeiro GuerraWim Vanden Berghe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.